WO2000005379A1 - Polynucleotide transporter protein - Google Patents
Polynucleotide transporter protein Download PDFInfo
- Publication number
- WO2000005379A1 WO2000005379A1 PCT/GB1999/002424 GB9902424W WO0005379A1 WO 2000005379 A1 WO2000005379 A1 WO 2000005379A1 GB 9902424 W GB9902424 W GB 9902424W WO 0005379 A1 WO0005379 A1 WO 0005379A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- tmv
- cell
- polynucleotide
- orf3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention relates to a novel protein and to the use of this protein, its functional equivalents or portions thereof, ' to transport a polynucleotide in the vascular system of a plant.
- KN1 also facilitates transport of its own mRNA
- the sequence specificity of post- transcriptional gene silencing implies that the signals involved m systemic transmission of the silencing state are polynucleotides that can enter the vasculature of the plant, move long distances and exit from the phloem (2, 4, 5) .
- Xoconostle- Cazares et al . Science (1999), Vol. 283, 94-97) have demonstrated that a plant endogenous protein CmPPl ⁇ moves from cell to cell, mediates the transport of sense and antisense RNA, and moves together with its own mRNA into the sieve elements delivering RNA into the long-distance translocation stream.
- viruses such as potato virus X (PVX)
- PVX potato virus X
- CP coat protein
- vascular parenchyma VP
- C companion
- SE enucleate sieve elements
- transport of a virus to and within vascular tissue implies movement from mesophyll cells to BS cells, from BS cells to VP and C cells and entry to SE .
- the exit from vascular tissue probably occurs in the reverse order. It has been observed that the plasmodesmata between these types of cells differ from those interconnecting mesophyll cells (18) .
- CP coat protein
- Umbravirus Members of the genus Umbravirus are unusual since they do not code for a CP but nonetheless accumulate and spread systemically very efficiently within infected plants (27, 28). umbraviruses utilise the coat protein of a co- infecting helper virus for encapsidation and transmission between plants. Typical helper viruses include members of the family Luteoviridae .
- genus Umbravirus include bean yellow vein-banding virus (BYVBV) , carrot mottle virus (CMoV) , carrot mottle mimic virus (CMoMV) , groundnut rosette virus (GRV) , lettuce speckles mottle virus (LSMV) , pea enation mosaic virus-2 (PEMV-2) and tobacco mottle virus (TMoV) .
- Other viruses have been identified as being putative members of the genus Umbravirus and include sunflower crinkle virus (SCV) , sunflower yellow blotch virus (SYBV) , tobacco bushy top virus (TBTV) and tobacco yellow vein virus (TYW) .
- RNA 2 of pea enation mosaic virus (PEMV-2) is now classified as an Umbravirus and its genome sequence was reported by Demler et al . , in J. Gen. Virol (1993), Vol 74, pages 1-14.
- the genome sequence of groundnut rosette virus was reported by Taliansky et al . , J. Gen. Virol. (1996), Vol 77, pages 2335-2345 and the genome sequence of carrot mottle mimic virus was published by Gibbs et al . , in Virology (1996), Vol 224, pages 310-313.
- RNA genome of GRV contains four open reading frames (ORFs) .
- ORFs open reading frames
- the two ORFs at the 5' -end of the RNA (0RF1 and 0RF2) are expressed by a -1 frameshift to give a single protein, which appears to be an RNA-dependent RNA polymerase.
- the other two ORFs overlap each other in different reading frames.
- 0RF4 encodes the 28 kDa cell-to-cell MP that contains stretches of similarity with several other viral MPs (28) .
- the ORF3 protein of Umbraviruses comprises two conserved domains: a highly basic domain which is a putative nucleic acid binding site, and a hydrophobic domain.
- the present invention provides the use of the ORF3 protein from an Umbravirus, or a functional equivalent thereof, to transport a pre-determined single stranded polynucleotide through the vascular system of a plant.
- the 0RF3 Umbravirus protein exhibits trans-activity by transporting a single stranded polynucleotide which is non-native m that Umbravirus .
- the term "functional equivalent” as used herein includes modified versions of the ORF3 protein of Umbraviruses which exhibit substantially the same level, or an improved level, of the biological activity (namely transport of a single-stranded polynucleotide molecule through the vascular system of a plant) compared to the naturally occurring protein.
- Modifications to the Umbravirus ORF3 protein which fall within this definition include (but are not limited to) versions of Umbravirus ORF3 having one or more of the following modifications: ammo acid deletions, ammo acid insertions and/or am o acid substitutions. Also included with this definition are modifications wnere whole domains of the protein are rearranged, deleted or substituted by alternative polypeptides, provided always that the biological activity level is retained or increased.
- the term "functional equivalent” also includes portions of the Umbravirus 0RF3 protein, provided again that the function (biological activity level) is maintained or increased.
- the functional equivalent or modified version of the ORF3 protein may retain at least 50% (preferably at least 60%, more usually at least 80% or more, such as 90% or 95%) homology with the wild-type sequence of such a protein.
- the single-stranded (ss) polynucleotide to be transported may be either RNA or DNA, although RNA is preferred since this avoids the need for a transcription step.
- the RNA to be transported is positive sense ssRNA (for example mRNA) .
- smgle-stranded polynucleotide of about 10 kb or more may be transported and to date we have been able to cause transport of a smgle-stranded polynucleotide of 6.7 kb .
- the smgle- stranded polynucleotide will encode a polypeptide or protein (these terms are used interchangeably herein) of interest.
- the polynucleotide is characteristic of a viral genome, especially a smgle-stranded positive sense viral genome.
- characteristic of a viral genome we include smgle-stranded polynucleotides which are associated with MPs de virus-encoded movement proteins) responsible for cell-to-cell movement.
- MPs de virus-encoded movement proteins
- cell-to-cell MPs include (but are not limited to) those found in plant viruses, for example as referred to by Lucas in Curr . Opm. Cell Biol . (1995), Vol 7, pages 673-680, oy Citovsky m Plant Physiol, (1993) Vol 102, pages 1071-1076; or by Camngton et al .
- the cell-to-cell MPs may be of plant origin, for example KN1 or the MPs discussed in references 1, 2, 4 and 5. Particular mention may be made of the Begrox ⁇ ovirus MPs (BV1 and BCD ; ORF4 of Umbraviruses ; PI of CaMV; and the MPs of TMV and TMV- like viruses (eg RCNMV, CMV and AMV) ; and homologous proteins m related viruses.
- Begrox ⁇ ovirus MPs BV1 and BCD ; ORF4 of Umbraviruses ; PI of CaMV; and the MPs of TMV and TMV- like viruses (eg RCNMV, CMV and AMV) ; and homologous proteins m related viruses.
- the present invention envisages providing an MP (optionally by provision of an MP-encoding polynucleotide) which will associate with and further facilitate transport throughout the plant of the smgle-stranded polynucleotide encoding a polypeptide or protein of interest.
- the present invention provides the use of an ORF3 protein from an Umbravirus, or a functional equivalent thereof, to transport a complex comprising a smgle-stranded polynucleotide associated with a cell-to-cell MP, in the vascular system of a plant.
- the cell-to-cell MP will associate with the smgle-stranded polynucleotide of interest and will transport that polynucleotide originally from the cell of its manufacture or introduction m a cell-to-cell manner to reach a cell adjacent to the vascular system of the plant.
- Potential mechanisms of this cell-to- cell movement are discussed above, but the present invention is not limited to any particular mode of cell-to-cell transport.
- the important feature with respect to the present invention is that the s gle- stranded polynucleotide becomes located in cells ad acent to the vascular system, enabling the 0RF3 Umbravirus protein, its functional equivalent or portion thereof, to facilitate rapid systemic transport of the polynucleotide via the vascular system.
- the ORF3 protein may be derived from any currently known, or subsequently discovered or reclassifled, Umbravirus . Mention may be made of known Umbraviruses which include bean yellow vem-band g virus (BYVBV) , carrot mottle virus (CMoV) , carrot mottle mimic virus (CMoMV) , groundnut rosette virus (GRV) , lettuce speckles mottle virus (LSMV) , pea enation mosaic virus- 2 (PEMV-2) and tobacco mottle virus (TMoV) ; and also of putative Umbraviruses which include sunflower crinkle virus (SCV) , sunflower yellow blotch virus (SYBV) , tobacco bushy top virus (TBTV) and tobacco yellow vein virus (TYW) .
- BYVBV bean yellow vem-band g virus
- CMV carrot mottle virus
- CMoMV carrot mottle mimic virus
- GRV groundnut rosette virus
- LSMV lettuce speckles mottle virus
- CMoMV Umbraviruses carrot mottle mimic virus
- PEMV-2 pea enation mosaic v ⁇ rus-2
- GMV groundnut rosette virus
- TMV tobacco mottle virus
- the ORF3 Umbravirus protein is the 27 kDa ORF3 protein of groundnut rosette virus (GRV) .
- the ORF3 Umbravirus protein is the 0RF3 protein of RNA 2 of pea enation mosaic virus (PEMV-2) or is the 0RF3 protein of tobacco mottle virus (TMoV) .
- the advantage of the invention is that the ORF3 Umbravirus protein encoded by the polynucleotide herein described will cause the single stranded polynucleotide encoding for the polypeptide or protein of interest to be systemically spread throughout the whole host plant or the host plant cells. Thus, widespread transfection of that polynucleotide sequence encoding the polypeptide or protein of interest will be achieved and thus the yield of the polypeptide or protein of interest will be enhanced.
- TMV(ORF3G) Direct localisation of TMV(ORF3G) in the phloem- associated cells such as bundle sheath and companion cells and in the sieve elements using immunogold labelling techniques with antibodies against the GRV ORF3 protein.
- TMV( ⁇ CP)-GFP vascular tissues in uninoculated leaves in the presence of TMV(ORF3G) resembles the normal unloading pattern of a virus from phloem (Roberts, A.G., Santa Cruz, S., Roberts, I. M., Prior, D.A.M., Turgeon, R. and Oparka, K.J (1997) The Plant Cell 9, 1381-1396) .
- the present invention provides a recombinant polynucleotide comprising a polynucleotide sequence which encodes the ORF3 protein of an Umbravirus, or a functional equivalent thereof.
- the 0RF3 protein encoded is derived from GRV, CMoMV, TMoV or PEMV-2, that is it has at least a 50% homology, preferably 60% homology, to the amino acid sequence of the native version thereof . More usually the 0RF3 protein will exhibit 80% (more preferably 90% or even 95%) homology with the native 0RF3 protein of GRV, CMoMV, TMoV or PEMV-2.
- Fig.10 and SEQ ID No 13 set out the novel polynucleotide sequence of the 0RF3 protein of TMoV.
- the present invention provides a polynucleotide having the nucleotide sequence of SEQ ID No 13, or at least 90%, more particularly 95% (preferably 98%) homology thereto.
- the recombinant polynucleotide according to the invention may also comprise a polynucleotide sequence encoding a polypeptide or protein of interest.
- the polypeptide or protein of interest may be of microbial (especially bacterial) , viral, plant, animal or synthetic origin.
- the polypeptide or protein of interest may be native or non-native to the host plant. Examples include surface antigens of viruses, growth factors, peptide hormones and the like.
- the recombinant polynucleotide according to the invention may also comprise a polynucleotide sequence encoding for a cell- to-cell MP.
- the recombinant polynucleotide may comprise a polynucleotide sequence encoding the ORF3 protein of an Umbravirus (preferably GRV, CMoMV, TMoV or PEMV-2) , or a functional equivalent thereof (preferably GRV, CMoMV, TMoV or PEMV-2) ; a polynucleotide sequence encoding for a protein or polypeptide of interest; and a polynucleotide sequence encoding for a cell-to-cell MP.
- Umbravirus preferably GRV, CMoMV, TMoV or PEMV-2
- a functional equivalent thereof preferably GRV, CMoMV, TMoV or PEMV-2
- the recombinant polynucleotide may comprise a polynucleotide sequence encoding the 0RF3 protein of an Umbravirus (or a functional equivalent thereof) and the ORF4 cell-to-cell MP of the same Umbravirus (or a functional equivalent thereof) , and a sequence encoding for a protein or polypeptide of interest .
- the recombinant polynucleotide of the invention may be in any form (for example DNA or RNA double or single stranded) but generally double-stranded DNA is most convenient. However, it may also be convenient to present the recombinant polynucleotide in the form of a viral vector and single-stranded positive-sense RNA vectors (for example those based on TMV or potato virus X) are suitable.
- polynucleotide encoding a protein or polypeptide of interest is introduced into the host plant in the form of DNA (eg cDNA)
- DNA eg cDNA
- RNA eg as in the form of an RNA viral vector
- the recombinant genetic construct according to the present invention may itself be part of a vector (for example an expression vector) .
- the recombinant polynucleotide may be formed by simply inserting a construct comprising the polynucleotide sequence (s) of interest in-frame into such a viral genome based vector (especially of a plant virus) .
- the introduced polynucleotide sequence (s) may even replace the coat protein sequence of the virus.
- Suitable viral vectors are well-known in the art.
- the recombinant polynucleotide according to the present invention may be incorporated into the genome of a host forming a transgenic organism, especially a transgenic plant. Any vectors or transgenic organisms comprising a recombinant polynucleotide as described herein form a further aspect of the present invention.
- the present invention provides a recombinant expression system able to express the 0RF3 protein of an Umbravirus (preferably the 27 kDa ORF3 protein of GRV, or its equivalent in CMoMV, TMoV or PEMV-2) , or a functional equivalent thereof.
- the recombinant expression system may also have the ability to express one or more proteins or polypeptides of interest and/or the ability to express a cell-to-cell MP .
- Vectors including such recombinant expression systems, especially those vectors based upon plant viruses, are also encompassed by the present invention.
- expression system is used herein to refer to a genetic sequence which includes a protein-encoding region and is operably linked to all of the genetic signals necessary to achieve expression of that region.
- the expression system may also include regulatory elements, such as a promoter or enhancer to increase transcription and/or translation of the protein encoding region or to provide control over expression.
- the regulatory elements may be located upstream or downstream of the protein encoding region or with the protein encoding region itself. Where two or more protein encoding regions are present these may use common regulatory element (s) or have separate regulatory element (s) .
- a host cell especially a plant host cell
- two or more distinct recombinant expression systems could be used to achieve widespread transmission of the polynucleotide encoding the polypeptide or protein of interest.
- a first expression system or vector comprising a recombinant polynucleotide encoding the ORF3 protein of an Umbravirus (especially GRV) may be used m combination with a second expression system comprising a recombinant polynucleotide encoding the protein or polypeptide of interest.
- Either of these recombinant polynucleotides may additionally encode for a suitable cell-to-cell MP .
- the cell-to-cell MP may be encoded by a third expression system, requiring triple inoculation of the host cell.
- the host cell could be transgenically engineered to express the cell-to-cell MP.
- the present invention comprises a transgenic organism, especially a transgenic plant wherein a polynucleotide sequence encoding the ORF3 protein of an Umbravirus , or a functional equivalent thereof, is stably incorporated into the genome of the host organism.
- the protein or polypeptide of interest may be introduced into the host transgenic plant as a separate construct.
- the cell-to-cell MP may either be encoded on the same construct as the protein or polypeptide of interest or may be present on a separate construct.
- the host cell is transgenically engineered to express both the ORF3 protein of an Umbravirus , or a functional equivalent thereof, and also a cell-to-cell MP.
- the resulting transgenic organism could then simply be transfected at a single site with a construct encoding the protein or polypeptide of interest.
- the combined action of the cell-to-cell MP and the ORF3 protein will ensure rapid transmission of the transfected construct and thus expression of the protein or polypeptide or interest throughout the organism.
- Suitable host cells include plant cells, whether present in cell culture or as part of plantlets, plant parts (including seeds) or whole plants. Host cells particularly worthy of mention include: for GRV the natural host plant is groundnut (Arachis hypogaea) , but GRV has also been transmitted to several other species of Leguminosae (Glycine max, Indiogofera nummulari folia, Macrotyloma uniflorus, Phaseolus vulgaris, Stylosanthes gracilis, S . guayensis, S . mucronata , S . j uncea , S .
- Glycine max Indiogofera nummulari folia
- Macrotyloma uniflorus Phaseolus vulgaris
- Stylosanthes gracilis S . guayensis
- S . mucronata S . j uncea
- Umbraviruses infect at least their natural host.
- carrot mottle mimic virus infects carrot plants; tobacco mottle virus infects tobacco plants; bean yellow vein-banding virus infects bean plants, and so on.
- the present invention provides a method of producing a target protein or polypeptide, said method comprising: introducing into a host plant cell one or more polynucleotides able to express: a) an 0RF3 protein of an Umbravirus or a functional equivalent thereof; and b) a cell-to-cell movement protein; and c) the target protein or polypeptide.
- the ORF3 protein is desirably chosen from GRV, PEMV-2, TMoV or CMoMV.
- the cell-to-cell movement protein may conveniently be the ORF4 protein of GRV, PEMV-2, TMoV or CMoMV.
- Fig.l Schematic representation of TMV-based vector, TMV(30B) and its derivatives expressing GRV ORF3 , PEMV- 2 ORF3 and GFP with and without deletion of the CP gene. Boxes represent open reading frames, lines represent untranslated sequences. MP, movement protein; CP, coat protein; GFP, green fluorescent protein; ORF3G, GRV ORF3 protein; ORF3P, PEMV-2 ORF3 protein; •, subgenomic promoters. Deleted sequences are indicated.
- Fig. 2 Symptoms of Nicotiana benthamiana plants infected with (a) TMV(30B) , (b) TMV( ⁇ CP) and (c) TMV(ORF3G) .
- Fig. 3 Representative Northern blot analysis of viral RNAs fxom inoculated (i) and uninoculated (u) leaves of Nicotiana benthamiana plants infected with TMV(30B), TMV(ORF3G) and TMV( ⁇ CP) , as indicated. Exposure time for autoradiography (2 hours and 24 hours) is indicated and the position of TMV genomic RNA is marked.
- Fig. 4 Nicotiana benthamiana plants photographed under long-wavelength UV light 8 days (a,b) and 12 days (c,d,e) after infection with (a,c) ' TMV(30B) -GFP, (b) TMV( ⁇ CP) -GFP, (d,e) TMV( ⁇ CP)-GFP + TMV(0RF3G). Inoculated (I) and systemically infected (S) leaves are indicated.
- Fig. 5 Schematic representation of the GRV ORF3 construct used for transformation of N. benthamiana .
- GRV ORF3 sequence was inserted in the pROK2 ⁇ vector between the 5' -end leader sequence of tobacco mosaic virus genomic R ⁇ A ( ⁇ leader) , located downstream from the 35S promoter of cauliflower mosaic virus (CaMV 35S) , and the transcriptional terminator from Agrobacterium tumefaciens nopaline synthase gene ( ⁇ OS ter) to give pROK2 ⁇ .GRV3.
- the ⁇ PII gene for neomycin phosphotransferase II was used as the selectable marker gene .
- Fig. 6 Symptoms in Nicotiana benthamiana plants infected with (a) TMV(30B), (b) TMV( ⁇ CP) and (c) TMV(ORF3P) .
- Fig. 7 Representative Northern blot analysis of viral RNAs from inoculated (i) and uninoculated (u) leaves of Nicotiana benthamiana plants infected with TMV( ⁇ CP) TMV(ORF3P) and TMV(30B) , as indicated. Exposure time for autoradiography is 24 hours.
- Fig. 8 Symptoms in Nicotiana clevelandii plants infected with (a) TMV(30B), (b) TMV( ⁇ CP) and (c) TMV(ORF3P) .
- Fig. 9 Representative Northern blot analysis of viral RNAs from inoculated (i) and uninoculated (u) leaves of Nicotiana clevelandii plants infected with TMV( ⁇ CP) , TMV(30B) and TMV(ORF3P), as indicated. Exposure time for autoradiography is 24 hours.
- Fig.10 Nucleotide sequence of TMoV ORF3 and, below, the amino acid sequence encoded by this ORF.
- pTMV(QRF3G) (Fig. 1) .
- a single nucleotide substitution (T ⁇ C) was introduced into the plasmid grmp2 (28) to change the initiation codon (AUG) of the ORF4 located inside the GRV 0RF3 to (ACG) by overlap extension PCR (31) using a pair of complementary mutagenic primers, one of which was 5 ' -GTCAAGTGTAATAAACGTCTTCGCAAGTG-3 ' (SEQ ID No 1) .
- This mutation is predicted to eliminate the 0RF4 , but does not change the amino acid sequence encoded by the ORF3.
- the fragment containing GRV ORF3 was amplified using oligonucleotides 5'- CATGATCGATATGGACACCACCC-3' (SEQ ID No 2) with a Clal site preceding 13 nucleotides (nt) identical to those of the 5' -end of GRV ORF3 as a forward primer and 5'- CATGCTCGAGTTACGTCGCTTTGC-3' (SEQ ID No 3) with a Xhol site preceding 14 nt complementary to those of the GRV RNA sequence downstream of 0RF3 as a reverse primer.
- the amplified fragment was cloned between the Pmel and Xhol sites of pTMV(30B) .
- pTMV( ⁇ CP) (Fig. 1) .
- the Pmll -Hpal fragment (nucleotides 5833-6465) carrying the native subgenomic promoter for the CP gene and the 5' part of this gene was excised from pTMV(30B) to give pTMV( ⁇ CP) .
- pTMV(30B) -GFP (Fig. 1) .
- the GFP gene was amplified using oligonucleotides 5' -GATCGTCGACATGAGTAAAGGAGAAG-3' (SEQ ID No 4) with a Sail site preceding 16 nt identical to those of the 5'- end of the GFP gene as a forward primer and 5' -GATCCTCGAGTTACGTCGCTTTGC-3' (SEQ ID No 5) with a Xhol site preceding 14 nt complementary to those of the 3'- end of the GFP gene as a reverse primer.
- the amplified product was cloned mto Xhol site of pTMV(30B) to give pTMV (30B) -GFP.
- pTMV( ⁇ CP) -GFP The Xhol - Hpal fragment (nucleotides 5782 to 6465 of the pTMV(30B) sequence) of pTMV(30B)- GFP carrying the subgenomic promoter and the 5' part of the CP gene, was excised to give pTMV ( ⁇ CP) -GFP .
- Biological assays of nucleic acid extracts from inoculated and uninoculated leaves of N. benthamiana were conducted on Nicotiana tabacum L cv. Xanthi nc, a local lesion host of TMV. Viral mfectivity was determined as the average number of local lesions per half leaf.
- Mesophyll protoplasts were isolated from fully expanded mature uninoculated leaves of plants infected with TMV(ORF3G) and TMV(30B) as described (34) .
- R ⁇ A Total R ⁇ A was isolated from leaf tissue or protoplasts as described (35) .
- total R ⁇ A preparations were denatured with formaldehyde and formamide .
- Electrophoresis was in 1.5% agarose gels (30) .
- R ⁇ A was transferred to Hybond ⁇ membrane by the capillary method with 20xSSC (3M sodium chloride and 0.3M sodium citrate, pH 7.0) and immobilized by UV crosslinkmg.
- dot blot hybridization analysis samples of R ⁇ A were spotted onto Hybond ⁇ nylon membrane and immobilized by UV crosslinkmg.
- Hybridization was done as described (30) with [ 32 P] R ⁇ A probes complementary to sequences of the TMV replicase gene [nucleotides 445 to 2675 of pTMV(30B)]. Quantitative analysis of dot blots was done by densitometry of the autoradiographic images, using a Bio Image Intelligent Quantifier Version 2.5.0. A dilution series of TMV RNA was used as concentration standard.
- GFP Fluorescence in Plants Plants were illuminated with long-wavelength UV light and photographed as described previously (29, 36) .
- GFP fluorescence in plant tissues was viewed with a Bio-Rad MRC 1000 confocal laser scanning microscope. The methods were as described previously (29, 36) .
- TMV(ORF3G) a Hybrid TMV with Replacement of the CP Gene with GRV ORF3.
- the inability of GRV to form conventional virus particles creates technical' difficulties in isolation of viral RNA and hence in generation of full-length cDNA clones to produce infective transcripts. This limits the potential of using a reverse genetics approach for functional analysis of GRV-encoded proteins. Therefore, we employed a gene replacement strategy to generate hybrids between TMV and GRV.
- the CP is not required for cell-to-cell movement of TMV but is essential for its long distance movement.
- TMV The CP gene of TMV was deleted and replaced by ORF3 of GRV in the TMV-based vector, TMV (30B), to give the hybrid TMV(ORF3G) (Fig. 1) .
- TMV ( ⁇ CP) induced mild chlorotic spots in inoculated N. benthamiana leaves by 5 days post-inoculation (DPI) , but no systemic symptoms were observed in these plants even five weeks after inoculation.
- TMV(30B) induced very severe systemic symptoms, first observed at 5 DPI (Fig. 2) .
- the infected plants were stunted, and showed strong mosaic and deformation of leaves.
- TMV(ORF3G) also induced systemic symptoms on N. benthamiana plants. At approximately 7 DPI expanding leaves at the top of the plant began to show some deformation followed by mild mosaic and rugosity at 10-12 DPI (Fig. 2) .
- TMV(ORF3G) R ⁇ A Accumulation of TMV(ORF3G) R ⁇ A in Inoculated and Systemically Infected Leaves.
- inoculated and upper uninoculated leaves were harvested and analyzed by inoculation of nucleic acid extracts onto the hypersensitive host, N. tabacum L. cv Xanthi nc .
- TMV (30B) R ⁇ A accumulated both in inoculated and in uninoculated systemically infected leaves (Table 1) .
- Both TMV ( ⁇ CP) and TMV (ORF3G) R ⁇ As also accumulated in inoculated leaves, but only TMV(ORF3G) spread systemically (Table 1) .
- Table 1 Accumulation of viral RNA in N. benthamiana plants inoculated with chimeric TMV-based viruses.
- Samples consisted of material obtained from 0. lg of tissue .
- TMV ( ⁇ CP) RNA was detected only in the nodes attached to inoculated leaves, whereas TMV (30B) and TMV(ORF3G) RNAs were present in all the nodes, including those at the shoot apex (data not shown) .
- Northern blot analysis of RNA samples isolated from the inoculated and uninoculated leaves confirmed the results of the biological assays, indicating that despite poor accumulation TMV(ORF3G) RNA spread systemically in N. benthamiana plants (Fig. 3) .
- Northern blot analysis was conducted using a cRNA probe corresponding to nucleotides 445 to 2675 of TMV RNA (as indicated above for the dot blot analysis) transcribed from a corresponding plasmid using [ 32 P] ATP.
- TMV(0RF3G) mesophyll protoplasts from uninoculated systemically infected leaves were isolated.
- RNA extracted from these protoplasts was analyzed by dot- blot hybridization. As shown in Table 2, viral RNA was detected in protoplasts isolated from leaves systemically infected with either TMV(30B) or TMV(ORF3G) . However, the amount of the TMV(ORF3G) RNA was approximately 11-fold lower than that of TMV(30B) RNA.
- TMV(ORF3G) Quantitation of viral RNA isolated from entire leaf tissues revealed a similar ratio (about 1:13) between the levels of accumulation of TMV(ORF3G) RNA and TMV (3OB) RNA.
- Table 2 The presence of viral RNA in mesophyll cells of the leaves systemically infected with TMV(ORF3G) .
- the viral RNA was quantitated by dot blot hybridization using a dilution series of TMV RNA as concentration standard. Data are mean ⁇ standard deviation from three independent experiments with three replicate plants in each.
- TMV(ORF3G) Complementation of the Long Distance Movement Defect of the TMV CP Deletion Mutant by TMV(ORF3G) .
- GFP is often used as a non- invasive reporter to monitor viral infections (29, 36, 37) .
- the GFP gene was inserted into the genomes of TMV(30B) and TMV ( ⁇ CP) to give TMV(30B)-GFP and TMV ( ⁇ CP) -GFP , respectively (Fig. 1).
- TMV( ⁇ CP) -GFP caused the development of green fluorescent foci, which were clearly visible under long-wavelength UV light starting on the third DPI.
- TMV(30B)-GFP Similar foci appeared at the same time after inoculation in leaves inoculated with TMV(30B) -GFP. However, the rate of enlargement of fluorescent foci induced by TMV( ⁇ CP)-GFP was significantly higher compared with those induced by TMV(30B)-GFP (Fig. 4). In contrast, biological assays conducted on nucleic acid extracts from inoculated leaves showed that TMV(30B)-GFP RNA accumulated to much higher levels than TMV( ⁇ CP)-GFP RNA (Table 1). Thus it seems, that in spite of the low rates of RNA accumulation, TMV( ⁇ CP)-GFP moves from cell to cell in inoculated leaves more efficiently than TMV (30B) -GFP.
- TMV( ⁇ CP)-GFP was coinoculated with TMV(ORF3G) onto N. benthamiana .
- the majority of the doubly infected plants showed systemic symptoms characteristic of TMV(ORF3G) and developed green fluorescent spots induced by TMV ( ⁇ CP) -GFP in both inoculated and uninoculated leaves (Fig. 4), implying systemic spread of the TMV ( ⁇ CP) -GFP in the presence of TMV(ORF3G) .
- TMV ( ⁇ CP)-GFP fluorescent spots included by TMV ( ⁇ CP) -GFP in the presence or absence of TMV(ORF3G) were practically indistinguishable, but in uninoculated leaves the fluorescence appeared only in the case of mixed TMV( ⁇ CP)-GFP + TMV(ORF3G) infection.
- the first indication of entry of TMV( ⁇ CP)-GFP into an uninoculated leaf in this case was the appearance of fluorescent flecks along veins on the lamina, indicating that the virus was being unloaded at discrete foci. After the appearance of these fluorescent flecks, some leaf veins became more clearly delineated by fluorescence (Fig.
- TMV( ⁇ CP)- GFP was unable to move long distance alone, these results suggest that TMV(ORF3G) can complement long distance movement of TMV( ⁇ CP) -GFP.
- the number of initial fluorescent flecks in uninoculated leaves generated as a result of complementation of TMV( ⁇ CP)- GFP by TMV(ORF3G), and the extent of their spread, were usually lower than in the case of TMV(30B)-GFP infection and varied significantly from leaf to leaf (Fig. 4C vs 4D and 3E) , probably reflecting differences in efficiencies of complementation which might depend on numerous factors including interference between virus variants.
- TMV(ORF3G) does not depend on TMV( ⁇ CP)-GFP for replication and spread and therefore may sometimes outcompete it, decreasing the efficiency of the complementation.
- the progeny virus that accumulated in the uninoculated leaves was analyzed by back inoculation first to a local lesion host of TMV, N. tabacum cv Xanthi ⁇ . Subsequent transfer of virus from individual lesions to a systemic host, N.
- benthamiana produced one of two phenotypes characteristic of each the original viruses: either systemic symptoms and no fluorescence [TMV(0RF3G)] or no systemic symptoms and fluorescence in inoculated but not in uninoculated leaves [TMV( ⁇ CP)- GFP] .
- Confocal laser scanning microscopy confirmed that TMV ( ⁇ CP) -GFP moved in the presence of TMV(ORF3G) to uninoculated leaves and showed that up to 90% of mesophyll cells in the area of fluorescent foci were infected with TMV ( ⁇ CP) -GFP .
- results presented here suggest that the GRV ORF3 protein may control entry to the vascular system at the level of the C cell / SE complex (45) , and perhaps also exit from phloem to mesophyll cells in uninoculated systemically infected leaves.
- ORF3 has been found in all three umbraviruses (GRV, pea enation mosaic virus 2 and carrot mottle mimic virus) sequenced to date (28, 46, 47) .
- the deduced ammo acid sequences of the corresponding proteins are also conserved (28) .
- Analysis of ammo acid sequences of the ORF3 proteins using the programs PileUp and PEPTIDESTRUCTURE revealed that the most conservative central region consists of a rather basic and highly hydrophilic domain, which seems to be exposed on the protein surface (ammo acids 108-130) , and a hydrophobic part (ammo acids 151-180) .
- the basic hydrophilic domain may possesses RNA-bmdmg capacity.
- a database search with the sequences of these proteins revealed no significant similarity with any other known viral or non-viral proteins (28) .
- the GRV ORF3 protein represents a novel class of trans-acting long distance movement factors. To the best of our knowledge, this is the first example of a nonstructural viral protein facilitating long distance movement of unrelated viral RNA. However, a prerequisite for the ORF3 -directed long distance spread is effective cell-to-cell movement of the dependent RNA. GRV ORF3 could not functionally replace CP in the long distance movement of PVX RNA, because in this hybrid virus CP was also required for the cell to cell movement (37) .
- GRV ORF3 Another interesting feature of the GRV ORF3 protein is that because of the inability of GRV to form virus particles this protein may be adapted to transport RNA in non-virion form. This process may more closely resemble long distance transport of endogenous plant macromolecules. Plant virus evolution may have apparently involved the acquisition of cellular genes (48) , and it is possible that the putative plant long distance movement factors that are necessary for normal plant growth and development were the progenitors to the GRV ORF3 protein. However, GRV ORF3 overlaps almost completely with ORF4 , and this arrangement seems typical in umbraviruses (28) .
- the ORF4 protein is a cell-to-cell movement protein that has clear similarities in sequence with the MPs of other plant viruses (28) , and all these MPs probably share a common origin.
- the ORF3 sequence seems unique to the umbraviruses and has most likely arisen as a result of "overprinting" (49) on ORF4 to give a functional, and perhaps structural, analogue of the hypothetical cellular long distance transport factor.
- umbraviruses may have evolved from a virus that had conventional cell-to-cell MP and CP genes. Once the ancestral umbravirus had developed an ORF3 , and acquired the ability for its RNA to be packaged by helper virus CP and thereby transmitted by the vector of the helper virus its own CP became expendable.
- expression in transgenic plants of the ORF3 protein may constitute a powerful approach to the modulation of plant transport processes and it may also be valuable in the design, environmental containment and complementation of plant virus vectors to produce pharmaceutical or industrial proteins.
- RNAs of potyviruses including RNAs of potyviruses, cucumoviruses , tobraviruses etc. as well as DNAs of geminiviruses, caulimoviruses etc. are being tested for their ability to be transported long- distances by GRV ORF3.
- GRV ORF3 protein Localization of GRV ORF3 protein in different cells of the vascular system is also being monitored.
- the fragment containing the ORF3 was amplified using oligonucleotides 5' -GTACTCTAGATGGACACCACCC-3 ' (SEQ ID No 6) with an Xbal site preceding 13 nucleotides (nt) identical to those of the 5' -end of GRV ORF3 as a forward primer and 5'- CATGGGTACCTTACGTCGCTTTGCGG-3' (SEQ ID No 7) with a Kpnl site preceding 16 nt complementary to those of the GRV RNA sequence downstream of ORF3.
- the amplified fragment was cloned between the Xhol and Kpnl sites of pROK2 ⁇ , a modified pROK2 , a binary plant transformation vector based on pBinl9 to give pROK2 ⁇ GRV3 (Fig. 5) .
- Pieces of Nicotiana benthamiana stem tissue were transformed as described by Benvenuto et al . (1991) .
- Transgenic shoots were regenerated on a selection medium containing kanamycin (100 ⁇ g/ml) . Rooted plantlets were transferred to sterilized compost and, after an adaptation period in a climate room at a humidity of 70%, were maintained in a glasshouse.
- GRV ORF3 The presence of entire GRV ORF3 sequences in all transgenic plants' was confirmed by PCR amplification with primers specific to termini of the inserted sequences. Reverse transcription-PCR analysis demonstrated expression of GRV ORF3 in transgenic plants.
- the transgenic plants may be used for analysis of long- distance movement of different nucleic acids, including viral RNAs and DNAs of viruses belonging to different groups, for example as described below.
- PVX was shown to require both the triple gene block (TGB) -encoded movement proteins and the CP for cell-to- cell and long-distance movement (15-17) .
- TGB triple gene block
- GRV ORF4 was substituted for the PVX CP gene
- the hybrid virus was able to move normally from cell to cell in inoculated leaves but not long distances (37) .
- progeny plants of two independently transformed lines (GRV3-2, GRV3-5) expressing GRV ORF3 were inoculated with PVX.4.GFP. ⁇ CP.
- Nontransformed plants were used as a control.
- the ability of the virus to move long distances was tested by confocal laser scanning microscopy. In all transformed and nontransformed plants green fluorescence developed in the inoculated leaves, indicating that the virus accumulated, spread from cell to cell and expressed GFP in these leaves. However fluorescence in noninoculated leaves was detected only in plants of the transformed lines.
- PEMV-2 ORF3 protein facilitates long-distance movement of TMV RNA in N. benthamiana and N. clevelandii plants
- a cDNA fragment containing PEMV-2 ORF3 was generated by reverse-transcription- PCR using PEMV-2 RNA as a template and oligonucleotide 5' -GCATGTCGACATCACCCGTAGTGAGAG-3' (SEQ ID No 8), with a Xhol site preceding 18 nt complementary to those of the PEMV-2 RNA sequence downstream of ORF3 , as a primer for synthesis of first strand cDNA and as a reverse primer for PCR, and oligonucleotide 5' -GGCCTTAATTAAATGGCGGTAGGGAAATATATGAC-3' (SEQ ID No 9), with a Pad site preceding 23 nt identical to those of the 5' -end of PEMV-2 ORF3 , as a forward primer for PCR.
- the amplified fragment was clo
- RNA Electrophoresis of RNA and Northern blot analysis were performed as described in Example 1 using [ 32 P] cDNA probes complementary to sequences of the TMV replicase gene (nucleotides 270 to 4254 of TMV RNA; TMV probe) and to sequences of the PEMV-2 0RF3 (nucleotides 2763 to 3474 of PEMV-2 RNA; PEMV probe) , labelled with [ 3 P] using a Random Primer DNA labelling kit.
- TMV(ORF3G) induced systemic symptoms in N. benthamiana plants.
- TMV(ORF3P) was also shown to induce systemic symptoms (Fig. 6) , and the symptoms were even more severe and appeared earlier (4-5 DPI) than those induced by TMV(ORF3G) (see Example 1) .
- N. clevelandii which is also a host for TMV and PEMV-2.
- TMV ( ⁇ CP) did not induce any systemic symptoms in N. clevelandii even 5 weeks post- inoculation.
- TMV(30B) induced in N. clevelandii very severe symptoms including strong stunting and deformation of leaves (Fig. 8) .
- TMV(ORF3P) also induced systemic symptoms in N. clevelandii plants, although they were milder and appeared later (at approximately 10-12 days post- inoculation) than those induced by TMV (30B) (Fig. 8) .
- TMV(ORF3P) spreads systemically not only in N. benthamiana plants but also in N. clevelandii .
- R ⁇ A was isolated from inoculated and upper uninoculated leaves of N. clevelandii and analysed by Northern blot hybridization.
- TMV(30B) RNA accumulated both in inoculated and uninoculated systemically infected leaves to high levels (Fig. 9) .
- Both TMV ( ⁇ CP) and TMV(ORF3P) also accumulated in inoculated leaves, but only to low levels compared with those of TMV (30B) .
- TMV(ORF3P) RNA was clearly detected in upper systemically infected leaves (Fig. 9) .
- TMV ( ⁇ CP) was never detected in uninoculated leaves.
- TMoV ORF3 protein facilitates long-distance movement of TMV R ⁇ A in N. benthamiana
- DsRNA double stranded (ds)RNA from TMoV- infected plants, sequencing and cloning of cDNA.
- DsRNA was prepared from a lOOg portion of TMoV-infected N. benthamiana leaf tissue by the method described earlier (28) .
- the first series of cD ⁇ A clones were produced using the dsR ⁇ A denatured with methylmercuric hydroxide as template, and random deoxyribonucleotide hexamers (Boehringer) as primer for synthesis of first-strand cDNA, as described by Taliansky et al .
- Plasmid pTMV( ⁇ CP) was described in Example 1 (Fig.l) .
- a cDNA fragment containing TMoV ORF3 was generated by PCR using pORF3T-12 as template and oligonucleotide 5'- GCATCTCGAGCTAGTATTTGTTCCCATCACAG-3' (SEQ ID No 11), with a Xhol site preceding 22 nt complementary to those of the TMoV RNA sequence downstream of 0RF3 , as reverse primer for PCR, and oligonucleotide 5' -GGCCTTAATTAATGGGCAAGTGTTGTAAATGTCAAC-3' (SEQ ID No 12) , with a Pad site preceding 24 nt identical to those of the 5 '-end of TMoV ORF3 , as forward primer.
- the amplified fragment was cloned between the Pad and Xhol sites of pTMV( ⁇ CP) to give pTMV(ORF3T) .
- This plasmid was transcribed into RNA as described in Example 1, and the transcripts were used to inoculate plants.
- Fig. 10 and SEQ ID No 13 shows the complete nucleotide sequence of TMoV ORF3.
- Amino acid sequence comparisons showed that the putative product of TMoV ORF3 (26 KDa) has significant homology with other umbraviral 0RF3 proteins.
- TMoV ORF3 protein displays 34% and 35% similarity, respectively, with the corresponding proteins encoded by GRV RNA and PEMV-2 RNA.
- the central part of the TMoV ORF3 -encoded protein in particular, is similar to those of 0RF3 proteins encoded by all other umbraviruses sequenced to date. This part consists of a very basic and highly hydrophilic domain (amino acids 93 to 116) , and a hydrophobic part (amino acids 136 to 164) .
- TMV(ORF3G) and TMV(ORF3P) induced systemic symptoms in N. benthamiana plants.
- TMV(ORF3T) was also shown to induce systemic symptoms, and the symptoms were as severe as in the case of TMV(ORF3P) and appeared 4-5 DPI.
- TMV(ORF3T) was able to move long distances rapidly, suggesting that the TMoV ORF3 protein mediated long- distance transport of heterologous viral (TMV) RNA in infected N. benthamiana plants.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99934968A EP1100924A1 (en) | 1998-07-24 | 1999-07-23 | Polynucleotide transporter protein |
AU50581/99A AU5058199A (en) | 1998-07-24 | 1999-07-23 | Polynucleotide transporter protein |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9816096.3 | 1998-07-24 | ||
GBGB9816096.3A GB9816096D0 (en) | 1998-07-24 | 1998-07-24 | Protein |
GB9818810.5 | 1998-08-29 | ||
GBGB9818810.5A GB9818810D0 (en) | 1998-08-29 | 1998-08-29 | Transporter protein |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000005379A1 true WO2000005379A1 (en) | 2000-02-03 |
Family
ID=26314101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002424 WO2000005379A1 (en) | 1998-07-24 | 1999-07-23 | Polynucleotide transporter protein |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1100924A1 (en) |
AU (1) | AU5058199A (en) |
WO (1) | WO2000005379A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057467A2 (en) * | 2001-01-19 | 2002-07-25 | Scottish Crop Research Institute | Use of umbravirus in protection against post-transcriptional gene silencing |
US20210355499A1 (en) * | 2020-05-12 | 2021-11-18 | University Of Maryland, College Park | Plant Vectors, Compositions and Uses Relating Thereto |
US20220002746A1 (en) * | 2018-11-13 | 2022-01-06 | University Of Maryland, College Park | Plant Vectors, Compositions and Uses Relating Thereto |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995021248A1 (en) * | 1994-02-03 | 1995-08-10 | The Scripps Research Institute | Method for using tobacco mosaic virus to overproduce peptides and proteins |
-
1999
- 1999-07-23 WO PCT/GB1999/002424 patent/WO2000005379A1/en not_active Application Discontinuation
- 1999-07-23 AU AU50581/99A patent/AU5058199A/en not_active Abandoned
- 1999-07-23 EP EP99934968A patent/EP1100924A1/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995021248A1 (en) * | 1994-02-03 | 1995-08-10 | The Scripps Research Institute | Method for using tobacco mosaic virus to overproduce peptides and proteins |
Non-Patent Citations (6)
Title |
---|
DEMLER,S.A., ET AL.: "the chimeric nature of the genome of Pea enation mosaic virus: the independent replication of RNA 2", JOURNAL OF GENERAL VIROLOGY, vol. 74, 1993, pages 1 - 14, XP002124273 * |
RYABOV, E.V., ET AL.: "intracellular location of two groundnut rosette umbravirus proteins delivered by PVX and TMV vectors", VIROLOGY, vol. 242, March 1998 (1998-03-01), pages 303 - 313, XP002124271 * |
RYABOV,E.V., ET AL.: "a plant virus-encoded protein facilitates long-distance movement of heterologous viral RNA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 96, February 1999 (1999-02-01), pages 1212 - 1217, XP002124275 * |
SKAF,J., ET AL.: "the coat protein is dispensable for the establishment of systemic infections by pea enation mosaic enamovirus", MOLECULAR PLANT MICROBE INTERACTIONS, vol. 10, no. 7, 1997, pages 929 - 932, XP000856484 * |
TALIANSKY, M.E., ET AL.: "role of cucumovirus capsid protein in long-distance movement within the infected plant", JOURNAL OF VIROLOGY, vol. 69, no. 2, February 1995 (1995-02-01), pages 916 - 922, XP002124274 * |
TALIANSKY,M.E., ET AL.: "complete nucleotide sequence and organization of the RNA genome of groundnut rosette umbravirus", JOURNAL OF GENERAL VIROLOGY, vol. 77, 1996, pages 2335 - 2345, XP002124272 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057467A2 (en) * | 2001-01-19 | 2002-07-25 | Scottish Crop Research Institute | Use of umbravirus in protection against post-transcriptional gene silencing |
WO2002057467A3 (en) * | 2001-01-19 | 2003-01-03 | Scottish Crop Res Inst | Use of umbravirus in protection against post-transcriptional gene silencing |
US20220002746A1 (en) * | 2018-11-13 | 2022-01-06 | University Of Maryland, College Park | Plant Vectors, Compositions and Uses Relating Thereto |
US20210355499A1 (en) * | 2020-05-12 | 2021-11-18 | University Of Maryland, College Park | Plant Vectors, Compositions and Uses Relating Thereto |
Also Published As
Publication number | Publication date |
---|---|
EP1100924A1 (en) | 2001-05-23 |
AU5058199A (en) | 2000-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stark et al. | Protection against potyvirus infection in transgenic plants: evidence for broad spectrum resistance | |
MacFarlane et al. | Plants transformed with a region of the 201-kilodalton replicase gene from pea early browning virus RNA1 are resistant to virus infection. | |
Pruss et al. | Plant viral synergism: the potyviral genome encodes a broad-range pathogenicity enhancer that transactivates replication of heterologous viruses. | |
Holt et al. | In vivo complementation of infectious transcripts from mutant tobacco mosaic virus cDNAs in transgenic plants | |
EP1385968B1 (en) | Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants | |
Annamalai et al. | Replication-independent expression of genome components and capsid protein of brome mosaic virus in planta: a functional role for viral replicase in RNA packaging | |
Rao et al. | Biological significance of the seven amino-terminal basic residues of brome mosaic virus coat protein | |
Duan et al. | Phenotypic variation in transgenic tobacco expressing mutated geminivirus movement/pathogenicity (BC1) proteins | |
Liu et al. | Functional replacement of the tobacco rattle virus cysteine-rich protein by pathogenicity proteins from unrelated plant viruses | |
Lin et al. | The open reading frame of bamboo mosaic potexvirus satellite RNA is not essential for its replication and can be replaced with a bacterial gene. | |
WO1990012107A1 (en) | Recombinant expression system based on satellite tobacco mosaic virus | |
AU2002214003A1 (en) | Virus-based amplification vector for plants | |
WO2002029068A2 (en) | Virus-based amplification vector for plants | |
Scheets | Maize chlorotic mottle machlomovirus expresses its coat protein from a 1.47-kb subgenomic RNA and makes a 0.34-kb subgenomic RNA | |
Sanchez-Navarro et al. | Engineering of alfalfa mosaic virus RNA 3 into an expression vector | |
Solovyev et al. | Movement of a barley stripe mosaic virus chimera with a tobacco mosaic virus movement protein | |
Deom et al. | Influence of heterologous tobamovirus movement protein and chimeric-movement protein genes on cell-to-cell and long-distance movement | |
US6849780B2 (en) | Plants resistant to cucumber mosaic virus strain V34 | |
KR20020013508A (en) | Multiple component rna vector system for expression of foreign sequences | |
WO1993021329A1 (en) | Virus resistant plants | |
Rubino et al. | Biologically active cymbidium ringspot virus satellite RNA in transgenic plants suppresses accumulation of DI RNA | |
EP1100924A1 (en) | Polynucleotide transporter protein | |
Pignatta et al. | Quantitative analysis of efficient endogenous gene silencing in Nicotiana benthamiana plants using tomato bushy stunt virus vectors that retain the capsid protein gene | |
WO2002057301A2 (en) | Gene silencing suppressor | |
Rao et al. | Defective movement of viruses in the family Bromoviridae is differentially complemented in Nicotiana benthamiana expressing tobamovirus or dianthovirus movement proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999934968 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09744498 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999934968 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999934968 Country of ref document: EP |